Jump to top menu Jump to main menu Jump to content

Pediatric hematology

Together with many dedicated experts, we aim to improve the diagnostics and treatment in our ever inspiring patient population.

About our Department

Our research

Background information

Pediatric hematologists treat the following patient groups:

  1. Children with abnormalities of hemostasis (e.g. hemophilia, von Willebrand’s disease, platelet disorders, isolated clotting factor deficiencies) or thrombosis (e.g. venous, arterial).
  2. Children with hemoglobinopathies (e.g. sickle cell disease, thalassemia) and other chronic hemolytic anemias (e.g. red cell membrane abnormalities, red cell enzyme deficiencies).
  3. Children with single cell cytopenias, pancytopenia, bone marrow failure syndromes.
  4. Children undergoing Immunohematology, transfusion medicine and stem cell transplantation medicine.

Overall aim

To improve the diagnostics and treatment of patients with a hematological condition.

Research focus areas

Investigator-initiated research programme:

  1. Personalized treatment in bleeding disorders and thrombosis.
  2. Sickle cell disease: identifying prognostic factors for complications and treatment outcome within national 'SCORE' consortium (Sickle Cell Outcome REsearch).
  3. Platelet disorders: improving diagnosis and management.

We also participate in pharmaceutical drug trials with innovative medication for hemostatic and thrombotic disorders. 

Principal Investigators

News, events and awards